Corrigendum to "Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension" [J Hepatol 62 (2015) 325-331]
1 Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK. Electronic address: r.mookerjee@ucl.ac.uk.
2 Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK.
3 Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK; Pathology Department, Faculty of Medicine, Minia University, Egypt.
4 Sections of Digestive Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.